Viewing nowJardiance Tablet 10 mg (Empagliflozin)
Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 201403744 · Approved 2014.08.12 · Insurance code 653501460
Improvement of blood glucose in type 2 diabetes, prevention of hospitalization for chronic heart failure, and slowing the progression of chronic kidney disease
This medication is used in conjunction with dietary and exercise therapy to improve blood sugar control in adults with type 2 diabetes. Additionally, it is administered cautiously to diabetic patients with accompanying cardiovascular disease. In patients with chronic heart failure, it is used together with other medications to reduce the risk of worsening heart failure and mortality from cardiovascular disease. In patients with chronic kidney disease, it helps reduce the risk of renal function deterioration and mortality from cardiovascular disease. Thus, this medication is effectively used for the treatment of diabetes, heart failure, and kidney disease.
Type 2 diabetes mellitus The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other blood-glucose-lowering medicines, including insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. Chronic heart failure The recommended dose of this medicine is 10 mg once daily. Chronic kidney disease The recommended dose of this medicine is 10 mg once daily. This medicine is administered in combination with other standard treatments for chronic kidney disease. Type 2 diabetes mellitus and chronic heart failure, chronic kidney disease When this medicine is administered concomitantly with a sulfonylurea or insulin, dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment Type 2 diabetes mellitus This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. Chronic heart failure This medicine should not be used in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. Chronic kidney disease This medicine may be used regardless of renal function. However, because experience is limited, initiation of this medicine is not recommended in patients with an estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73m2. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered (see Precautions for Use, 4. General Precautions).
This medication should not be used in patients with allergies to the active ingredient or any components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Furthermore, patients with lactose intolerance or specific genetic metabolic disorders should avoid this medication. Patients with diminished renal function should use this medication cautiously and kidney function should be regularly monitored before and during treatment. It is not recommended for patients with severe kidney impairment or those on dialysis. When taken with insulin or insulin secretagogues like sulfonylureas, there may be a risk of hypoglycemia, so dosage adjustments may be necessary. This medication can cause various side effects such as hypoglycemia, genital infections, urinary tract infections, volume depletion, and increased urination. Elderly patients or those at risk for volume depletion should be particularly cautious of side effects. Severe metabolic disturbances such as ketoacidosis can occur, so if symptoms like vomiting, abdominal pain, or difficulty breathing arise, immediate consultation with a healthcare provider is required. This medication may also pose a risk of liver damage, so symptoms of liver dysfunction should be reported. Additionally, there is a rare risk of severe infections such as necrotizing fasciitis, so if pain, swelling, or redness occurs around the genital area, immediate medical attention is necessary. Women who are pregnant or planning to become pregnant should avoid this medication, and if pregnancy is confirmed, it should be discontinued immediately. Nursing mothers should also discontinue breastfeeding while taking this medication. It is not used in children under the age of 18 as its safety and efficacy have not been established. When taking this medication, caution should be exercised to reduce the risk of hypoglycemia while driving or operating machinery. There have been no reports of specific toxicity with overdose, but if symptoms occur, immediate medical attention should be sought. This medication should be kept out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.
Light yellow, round, biconvex film-coated tablet with rounded edges
30 tablets/PTP [(10 tablets/PTP * 3)], 10 tablets/PTP [(10 tablets/PTP * 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Empagliflozin 10mg
Tablet · Prescription medication
Keeps Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.